Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary …
Pulmonary hypertension (PH) is a frequent complication of interstitial lung disease (ILD).
Although PH has mostly been described in idiopathic pulmonary fibrosis, it can manifest in …
Although PH has mostly been described in idiopathic pulmonary fibrosis, it can manifest in …
Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017)
K Fukuda, H Date, S Doi, Y Fukumoto… - Circulation …, 2019 - jstage.jst.go.jp
Pulmonary hypertension remained an unexplained intractable disease with poor prognosis.
In the last 2 decades, however, the diagnosis and treatment methods for this disease …
In the last 2 decades, however, the diagnosis and treatment methods for this disease …
The effect of borderline pulmonary hypertension on survival in chronic lung disease
Background: The impact of the new “borderline” hemodynamic class for pulmonary
hypertension (PH)(mean pulmonary artery pressure [mPAP], 21–24 mm Hg and pulmonary …
hypertension (PH)(mean pulmonary artery pressure [mPAP], 21–24 mm Hg and pulmonary …
Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
R Parikh, I Konstantinidis, DM O'Sullivan… - Pulmonary …, 2022 - Wiley Online Library
Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD)
patients resulting in poor functional status and worse outcomes. Early recognition of PH in …
patients resulting in poor functional status and worse outcomes. Early recognition of PH in …
Progress in the treatment of pulmonary hypertension associated with interstitial lung disease
SD Nathan - American Journal of Respiratory and Critical Care …, 2023 - atsjournals.org
Pulmonary hypertension, frequently complicating the course of patients with fibrotic
interstitial lung disease, is associated with significantly increased morbidity and mortality …
interstitial lung disease, is associated with significantly increased morbidity and mortality …
Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis
A Nakano, H Ohkubo, H Taniguchi, Y Kondoh… - Scientific reports, 2020 - nature.com
Computed tomography (CT) assessment of the cross-sectional area of the erector spinae
muscles (ESMCSA) can be used to evaluate sarcopenia and cachexia in patients with lung …
muscles (ESMCSA) can be used to evaluate sarcopenia and cachexia in patients with lung …
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide
AR García, L Piccari - Current Opinion in Pulmonary Medicine, 2022 - journals.lww.com
Correct phenotyping is key to appropriate management of PH associated with COPD. The
lack of evidence regarding the use of pulmonary vasodilators in PH-COPD may be due to …
lack of evidence regarding the use of pulmonary vasodilators in PH-COPD may be due to …
Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients
V Averjanovaitė, L Gumbienė, I Zeleckienė… - Medicina, 2023 - mdpi.com
This article provides a comprehensive overview of the latest literature on the diagnostics and
treatment of pulmonary hypertension (PH) associated with interstitial lung disease (ILD) …
treatment of pulmonary hypertension (PH) associated with interstitial lung disease (ILD) …
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality
Objective A post-hoc analysis of the INCREASE trial and its open-label extension (OLE) was
performed to evaluate whether inhaled treprostinil has a long-term survival benefit in …
performed to evaluate whether inhaled treprostinil has a long-term survival benefit in …